| GlycA | Fisher transformation | |
---|---|---|---|
RA | Controls | P value | |
Markers of disease activity and inflammation | |||
 Disability (HAQ-DI) | 0.28 | NA | NA |
 Pain (VAS) (mm) | 0.08 | 0.11 | 0.91 |
 Disease activity (DASESR-28) | 0.54 ‡ | NA | NA |
 ESR (mm/hour) | 0.71 ‡ | 0.24 | 0.02 |
 hsCRP (mg/l) | 0.73 ‡ | 0.32 †| 0.01 |
 IL-1β (pg/ml) | 0.19 | 0.08 | 0.62 |
 IL-6 (pg/ml) | 0.28 †| −0.14 | 0.05 |
 IL-8 (pg/ml) | −0.20 | −0.07 | 0.56 |
 IL-18 (pg/ml) | −0.14 | 0.41 †| 0.01 |
 TNFα (pg/ml) | −0.09 | −0.14 | 0.82 |
Measures of adiposity and insulin resistance | |||
 BMI (kg/m2) | 0.16 | 0.38 †| 0.28 |
 Waist circumference (cm) | 0.12 | 0.38 †| 0.22 |
 Total abdominal adiposity (cm2) | 0.31 †| 0.36 †| 0.80 |
 Abdominal subcutaneous adiposity (cm2) | 0.26 | 0.34 †| 0.70 |
 Abdominal visceral adiposity (cm2) | 0.25 | 0.21 | 0.86 |
 Thigh subcutaneous adiposity (cm2) | 0.21 | 0.55 ‡ | 0.08 |
 Thigh intermuscular adiposity (cm2) | 0.06 | 0.18 | 0.60 |
 Thigh muscle density (Hu) | −0.33 †| −0.14 | 0.40 |
 Fasting insulin (mU/l) | 0.18 | 0.37 †| 0.38 |
 Fasting glucose (mg/dl) | 0.35 †| 0.16 | 0.36 |
 HOMA | 0.17 | 0.39 †| 0.30 |
 IS index (×10–5.min−1/(pmol/l)) | −0.26 | −0.34 †| 0.70 |
 Acute insulin response (pmol/l) | 0.05 | 0.48 †| 0.04 |